Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  DexCom, Inc.    DXCM   US2521311074

DEXCOM, INC. (DXCM)

7
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/23/2015 01/26/2015 01/27/2015 01/28/2015 01/29/2015 Date
57.94(c) 62.78(c) 62.32(c) 60.59(c) 61(c) Last
437 910 1 388 125 805 611 794 238 610 869 Volume
-0.29% +8.35% -0.73% -2.78% +0.68% Change
More quotes
Company
DexCom, Inc. is a medical device manufacturing company.The company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 249 M
EBIT 2014 -25,5 M
Net income 2014 -26,4 M
Debt 2014 -
Yield 2014 -
Sales 2015 356 M
EBIT 2015 0,30 M
Net income 2015 -1,46 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 18,7x
Capi. / Sales 2015 13,1x
Capitalization 4 670 M
More Financials
Latest news on DEXCOM, INC.
01/29 DEXCOM : to Present at 4th Annual Leerink Partners Global Healthcare Conference
01/29 DEXCOM : FDA OKs Dexcom G4 Platinum Continuous Glucose Monitoring System with Sh..
01/26 DEXCOM : FDA Approves Dexcom G4 Platinum Continuous Glucose Monitoring System wi..
01/14 DEXCOM : Kevin Sayer Assumes Role of President and Chief Executive Officer; Terr..
01/13 DEXCOM : Results of Operations and Financial Condition (form 8-K)
01/12 DEXCOM : to Participate at J.P. Morgan Healthcare Conference
01/08 DEXCOM : Makes New Executive Promotions
01/07 DEXCOM : to Present at 33rd Annual J.P. Morgan Healthcare Conference
More news
Sector news Medical Equipment, Supplies & Distribution - NEC
02:11a SMITH & NEPHEW : *traders: credit suisse raises smith & nephew price target to 1..
01/29 C R BARD : beats Street 4Q forecasts
01/29 C R BARD : Bard Announces Fourth Quarter Results
Plus d'actualités du secteur Medical Equipment, Supplies & Distribution - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF